Laboratory research use only. Not for human or animal consumption.

Peptides

View as Grid List
Sort by

Tirzepatide

A dual GIP/GLP-1 medication class item reviewed for appetite, weight, and glucose management.

AppetiteWeight
More library details

Research context

  • Acts through incretin pathways that influence satiety and glucose handling.
  • Often produces stronger appetite effects than GLP-1-only approaches for some users.

Review before use

  • Review prescription source, escalation, GI tolerance, and lean-mass preservation plan.
  • Keep protein, resistance training, and constipation prevention visible in the app.

Evidence notes

  • Dual GIP/GLP-1 receptor agonist medication class studied for glucose control, appetite, and body-weight outcomes.
  • Clinical review should include GI tolerance, gallbladder/pancreatitis risk, and lean-mass preservation.

Cautions

  • Medical supervision is required.
  • Discuss pancreatitis, gallbladder, thyroid cancer history, and medication interactions.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

Call for pricing

VIP

A peptide discussed for inflammation, respiratory, gut, and autonomic signaling contexts.

InflammationRespiratory
More library details

Research context

  • Reviewed for immune, vascular, and smooth-muscle signaling.
  • Sometimes discussed in chronic inflammatory or respiratory contexts.

Review before use

  • Review diagnosis, blood pressure, respiratory status, and medication interactions.
  • Use objective measures when breathing symptoms are involved.

Cautions

  • Respiratory symptoms need medical evaluation.
  • Potential blood-pressure effects require caution.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

$36.00